Business

Pfizer, Moderna Covid-19 vaccine may be approved for use within a few weeks

Pfizer and Modena COVID-19 vaccines could be ready for US approval and distribution within a few weeks, and when they are ready to start vaccination soon this year, US Secretary of Health and Welfare Alex Azar Said on Wednesday.

The states and territories are ready to begin distributing vaccines within 24 hours of regulatory approval, officials said in a phone call with reporters, with complex refrigeration requirements for all Americans. He added that it does not preclude access to the vaccine.

“Currently, there are two safe and highly effective vaccines that have been approved by the Food and Drug Administration and can be distributed within a few weeks,” Azar said in a briefing on the COVID-19 vaccine and the government’s Warpspeed Operation Program for Treatment. I mentioned in. According to officials, one million doses of the two vaccines will both need to be given twice, about every four weeks, and will be available by the end of the year. The two companies would then be able to produce more than 40 million doses per month for Americans, they added.

The Moderna vaccine may be approved within 7-10 days after Pfizer receives an Emergency License (EUA). They said full formal approval is likely to follow the EUA by about three months. In addition, US officials said two more vaccines are likely to prepare early data in the coming weeks.

Monsef Slawi, head of the COVID-19 vaccine program in the United States, said there were no restrictions on who would get which vaccine. Government officials and private sector companies are ready to distribute the vaccine across the country, both with approximately 95% effectiveness in major trials. Much of the actual vaccine distribution is supervised by the team in which it is deployed. According to President-elect Joe Biden, who will take office on January 20.

Dear reader,

Business Standards has always worked hard to provide you with up-to-date information and commentary on developments that interest you and have a wide range of political and economic impacts on your country and the world. Your encouragement and constant feedback on how to improve our offerings only strengthened our determination and commitment to these ideals. Even during these difficult times resulting from Covid-19, we keep you up to date with credible news, authoritative views, and sharp commentary on issues of relevant topics. I will continue to promise to keep it.
However, there is a request.

We need more support to continue to provide higher quality content as we fight the economic impact of the pandemic. Our subscription model has seen encouraging reactions from many who subscribe to our online content. More subscriptions to our online content can only help us reach our goal of providing you with better and more relevant content. We believe in free, fair and reliable journalism. Your support through more subscriptions will help us practice the journalism we are committed to.

Supporting high quality journalism, Subscribe to business standards..

Digital editor



Pfizer, Moderna Covid-19 vaccine may be approved for use within a few weeks

Source link Pfizer, Moderna Covid-19 vaccine may be approved for use within a few weeks

Related Articles

Back to top button